Correction: Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus (Journal of Ovarian Research, (2022), 15, 1, (130), 10.1186/s13048-022-01054-5)

Uksha Saini, Brentley Q. Smith, Kalpana Deepa Priya Dorayappan, Ji Young Yoo, G. Larry Maxwell, Balveen Kaur, Ikuo Konishi, David O’Malley, David E. Cohn, Karuppaiyah Selvendiran

Research output: Contribution to journalComment/debatepeer-review

Abstract

Following publication of the original article [1], the authors identified an error in Figs. 1, 5 and Additional file. The correct figures are shown below and updated Additional file 2 is also provided in this article. Also, the Ethics approval and consent to participate section was modified, below is the correct statement. The original article has been corrected.

Original languageEnglish (US)
Article number38
JournalJournal of Ovarian Research
Volume16
Issue number1
DOIs
StatePublished - Dec 2023
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Correction: Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus (Journal of Ovarian Research, (2022), 15, 1, (130), 10.1186/s13048-022-01054-5)'. Together they form a unique fingerprint.

Cite this